What Is End-of-Life Care Like for Epithelioid Hemangioendothelioma (EHE)?
By CRYSTAL BAI •
The short answer: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with unpredictable behavior — some patients live for decades while others progress rapidly. End-of-life care focuses on symptom management, especially pain and fluid management, with palliative care specialists experienced in rare cancers playing a key role.
Understanding EHE and Its Disease Course
Epithelioid hemangioendothelioma (EHE) is an extremely rare vascular tumor that arises most commonly in the liver, lungs, and bones, though it can occur anywhere. Unlike most cancers, EHE's behavior is genuinely unpredictable — some patients have stable disease for years, while others experience rapid progression. This uncertainty makes advance care planning especially important.
EHE is not typically curable in the metastatic setting, and many patients eventually reach a point where disease-directed treatment is no longer providing benefit.
When Disease Becomes Advanced
In advanced EHE, the pattern of symptoms depends on the organ systems involved:
- Liver-dominant EHE: Liver failure signs — jaundice, ascites (fluid buildup), fatigue, abdominal pain, coagulopathy
- Lung-dominant EHE: Pleural effusions, breathlessness, respiratory failure
- Bone-dominant EHE: Bone pain, fracture risk, hypercalcemia
- Multi-organ involvement: Combination of above symptoms as disease spreads
Palliative and Hospice Care for EHE
Because EHE is rare, many general hospice providers have limited experience with it. Seeking a palliative care team familiar with rare vascular tumors or sarcomas is ideal. Key palliative priorities include:
- Pain management: Multi-modal pain control for liver capsule distension or bone involvement
- Ascites management: Paracentesis (fluid drainage) or palliative drainage catheters for comfort
- Breathlessness: Low-dose opioids are highly effective for dyspnea management
- Steroid use: Often helpful for appetite, energy, and inflammatory symptoms short-term
- Nutritional support: Addressing appetite changes and liver-related nutritional complications
Clinical Trial Considerations at End of Life
The EHE community has active research underway, including trials of YAP/TAZ inhibitors targeting the WWTR1-CAMTA1 fusion gene. Some patients wish to continue pursuing trials even in advanced illness; others prioritize comfort and quality of life. These decisions are deeply personal and should be made with full information about what participation entails physically and logistically.
EHE Community Resources
The EHE Awareness Organization (eheawareness.org) is the primary patient advocacy group for EHE. They maintain a physician registry, clinical trial database, and peer support network — invaluable for a disease this rare. Renidy can help connect EHE patients with death doulas experienced in rare disease navigation.
Frequently Asked Questions
Is EHE always fatal?
EHE has highly variable outcomes. Some patients with stable, low-burden disease live for many years or even decades without active treatment. Others progress rapidly. Unlike most cancers, EHE doesn't always follow a predictable trajectory, which makes prognosis conversations with oncologists essential — and sometimes frustratingly uncertain.
What is the life expectancy with metastatic EHE?
Prognosis with metastatic EHE is highly variable — median survival in older studies was 4-5 years from diagnosis, but many patients exceed this, especially those with liver-dominant disease that progresses slowly. The field is evolving rapidly with new targeted therapies, and individual prognosis should be discussed directly with an EHE specialist.
Is hospice appropriate for EHE patients?
Hospice is appropriate when an EHE patient and oncologist agree that disease-directed treatment is no longer providing meaningful benefit and life expectancy is estimated at 6 months or less. Because EHE is unpredictable, some patients 'graduate' from hospice if their condition stabilizes — this is possible and not uncommon.
What EHE-specific symptoms need palliative management?
Common symptoms requiring palliative attention in advanced EHE include: ascites (abdominal fluid) causing pressure and discomfort, bone pain from osseous metastases, liver pain from hepatic involvement, fatigue, and breathlessness from pleural effusions. Each requires tailored management.
Where can I find EHE specialists?
The EHE Awareness Organization (eheawareness.org) maintains a list of physicians with EHE experience. Major sarcoma centers — including MD Anderson, Memorial Sloan Kettering, and Dana-Farber — are most likely to have seen EHE patients and can provide specialist consultation.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.